STERIS vs Zimmer Biomet: revenue, profit, margins and growth compared
STERIS brought in $5.9B of revenue in fiscal 2026, Zimmer Biomet $8.2B in fiscal 2025. Revenue changed by +8.7% at STERIS and +7.2% at Zimmer Biomet on the year before, so STERIS grew faster. STERIS kept 13.2% of its revenue as net profit, Zimmer Biomet 8.6%. Free cash flow was $972.4M at STERIS and $1.5B at Zimmer Biomet.
Fiscal years as each company reports them; the two may end in different months.
Questions about STERIS and Zimmer Biomet
Which is bigger by revenue, STERIS or Zimmer Biomet?
Zimmer Biomet is bigger by revenue: $8.2B in fiscal 2025, against $5.9B for STERIS in fiscal 2026.
Which keeps more of its revenue as profit, STERIS or Zimmer Biomet?
STERIS had a net margin of 13.2% in fiscal 2026; Zimmer Biomet had 8.6% in fiscal 2025.
Which grew revenue faster, STERIS or Zimmer Biomet?
In their latest fiscal years revenue changed by +8.7% at STERIS and +7.2% at Zimmer Biomet.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.